ClinicalTrials.gov
public full text
Public Domain
Pravastatin Sodium 80 mg Tablets Under Fasting Conditions
The objective of this study is to evaluate the comparative bioavailability between pravastatin sodium 80 mg tablets (Distributed by Teva Pharmaceuticals, USA) and Pravachol® 80 mg tablets (Bristol Myers Squibb, USA), after a single-dose in healthy subjects under fasting conditions.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions#1128078
- Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions#894333
- Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions#1032545
- Pravastatin Sodium 40 mg Tablets Food Challenge Study#811163
- Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers#805644
Record · ID 876459
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive